Brimonidine Nitroso impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine eye drops is used alone or together with other medicines to lower pressure inside the eye that is caused by open-angle glaucoma or ocular (eye) hypertension. This medicine is an alpha-adrenergic agonist. Brimonidine Nitroso impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso impurity 1 chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide .Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso impurity 1. We supply Brimonidine Nitroso impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141651 |
| CAS No | NA |
| Mol.F. | C22H18ClN3O6 |
| Mol.Wt. | 455.85 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141652 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141653 |
| CAS No | NA |
| Mol.F. | C14H22N2O3 |
| Mol.Wt. | 266.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141654 |
| CAS No | NA |
| Mol.F. | C8H18N2O5 |
| Mol.Wt. | 222.24g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141655 |
| CAS No | NA |
| Mol.F. | C14H22N2O2 |
| Mol.Wt. | 250.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141656 |
| CAS No | NA |
| Mol.F. | C11H14N2O3 |
| Mol.Wt. | 222.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141657 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141658 |
| CAS No | NA |
| Mol.F. | C14H21N3O3 |
| Mol.Wt. | 279.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141659 |
| CAS No | NA |
| Mol.F. | C15H23N3O4 |
| Mol.Wt. | 309.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141660 |
| CAS No | NA |
| Mol.F. | C8H14N2O2 |
| Mol.Wt. | 170.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141661 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141662 |
| CAS No | NA |
| Mol.F. | C11H16N2O2 |
| Mol.Wt. | 208.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141663 |
| CAS No | NA |
| Mol.F. | C26H23N9O3 |
| Mol.Wt. | 509.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141664 |
| CAS No | NA |
| Mol.F. | C21H14N8O4 |
| Mol.Wt. | 442.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141665 |
| CAS No | NA |
| Mol.F. | C23H24ClFN8O2 |
| Mol.Wt. | 498.95 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141666 |
| CAS No | NA |
| Mol.F. | C17H22ClN3O3 |
| Mol.Wt. | 351.8 |
| INV STATUS | CUSTOM SYNTHESIS |